DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
|You are receiving this because you have an account on www.oneGRAVESvoice.com|
|To unsubscribe from these emails, click here|
Trusted Resources: News & Meetings
Latest announcements and gatherings
Prevent Blindness is excited to announce the launch of the first ever art therapy program for people with Thyroid Eye Disease and their care partners. The Prevent Blindness Art Therapy Program participants will:
• Partake in eight weekly 90-minute in-person or virtual sessions to create art using a variety of artistic media.
• Explore art therapy as a way to cope with feelings of isolation, anxiety and depression.
• Discover an opportunity to build community and connections with other people who are affected by Thyroid Eye Disease (TED) and express thoughts and feelings through art.
• Interact with registered art therapists who will tailor the program topics, themes and materials for people affected by TED.
Who Is Eligible to Apply?
Individuals with thyroid eye disease and their care partners (spouses, family members, friends, loved ones).
April 02, 2022
This event has ended.
Evidence & EducationRandomized Controlled Trial of Rituximab in Patients With Graves’ OrbitopathyContext: Graves' orbitopathy (GO) is a ...
Evidence & EducationRelation Between Therapy for Hyperthyroidism and the Course of Graves’ OphthalmopathyBackground: The chief clinical characte...
Evidence & EducationTEPEZZA (teprotumumab-trbw)- Frequently Asked Questions1. What is TEPEZZA? TEPEZZA is the firs...
Community CenterBattling Graves’ Disease: When Everything Changed PodcastIn this episode of When Everything Chang...
Community CenterNatasha’s Story – HyperthyroidismNatasha completed the London Marathon in...
Evidence & EducationKnowledge of Thyroid Eye Disease in Graves’ Disease Patients With and Without OrbitopathyBackground: Thyroid eye disease (TED) d...
Evidence & EducationEnfermedad de Grave’s FAQ¿Qué es la enfermedad de Grave’s? L...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.